Allergan Inc., the Irvine drug maker that’s Orange County’s second most valuable company after Broadcom Corp., got a bullish nod from Banc of America Securities, which started tracking the company.

NEW YORK, May 1 (Reuters) - Allergan Inc said first-quarter earnings fell by more than half as sales of its Botox anti-wrinkle drug and its medical devices fell, sending the company's shares down 6.2 ...

Allergan Inc. saw a smoother first quarter for Botox and sales of other medical cosmetic products, which took a hit during the recession. Stronger sales of wrinkle-fighting Botox as well as skin ...

A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million. The lawsuit, filed by Ireland-based ...

LONDON (Reuters) - Britain's healthcare cost-effectiveness body NICE has changed its mind on Allergan's anti-wrinkle injection Botox and decided it is worth paying for on the state-funded health ...

BOSTON (CBS.MW) -- Medical products conglomerate Allergan reported a 13.7 percent jump Wednesday in pharmaceutical revenue for the second quarter, largely attributed to strong sales of its eye-care ...

Mylan and Revance Therapeutics announced plans to develop and commercialize a biosimilar to Allergan’s Botox, TheStreet reports. Here’s what you should know. 1. Market analysts believe the deal puts ...

Federal officials are trying to determine the source of Botox injections — some of the shots potentially counterfeits — linked to an outbreak of botulism-like illnesses in several U.S. states. The ...

CHICAGO/WASHINGTON (Reuters) - Allergan Inc has agreed to plead guilty and pay $600 million to resolve a federal probe of its marketing practices for the injectable wrinkle smoother Botox, the company ...

Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...

Valeant Pharmaceuticals announced yesterday that it plans to acquire Allergan with the help of investor Bill Ackerman. Should the plan succeed, the acquisition would create a dermatology and ...